Xanthine oxidase inhibition by febuxostat attenuates experimental atherosclerosis in mice.
about
NRF2, a Key Regulator of Antioxidants with Two Faces towards CancerLinking uric acid metabolism to diabetic complicationsRole of Uric Acid Metabolism-Related Inflammation in the Pathogenesis of Metabolic Syndrome Components Such as Atherosclerosis and Nonalcoholic SteatohepatitisHypaphorine Attenuates Lipopolysaccharide-Induced Endothelial Inflammation via Regulation of TLR4 and PPAR-γ Dependent on PI3K/Akt/mTOR Signal Pathway.Early onset hyperuricemia is a prognostic marker for kidney graft failure: Propensity score matching analysis in a Korean multicenter cohort.Xanthine oxidase inhibition by febuxostat attenuates stress-induced hyperuricemia, glucose dysmetabolism, and prothrombotic state in miceFocal induction of ROS-release to trigger local vascular degenerationCrossroads between peripheral atherosclerosis, western-type diet and skeletal muscle pathophysiology: emphasis on apolipoprotein E deficiency and peripheral arterial disease.The Effects of Xanthine Oxidoreductase Inhibitors on Oxidative Stress Markers following Global Brain Ischemia Reperfusion Injury in C57BL/6 Mice.Cytochrome P450 1B1 Contributes to the Development of Atherosclerosis and Hypertension in Apolipoprotein E-Deficient Mice.Transient Receptor Potential Ankyrin 1 Channel Involved in Atherosclerosis and Macrophage-Foam Cell Formation.Rationale and design of a multicenter randomized study for evaluating vascular function under uric acid control using the xanthine oxidase inhibitor, febuxostat: the PRIZE study.Hydroxysafflor Yellow A Inhibits LPS-Induced NLRP3 Inflammasome Activation via Binding to Xanthine Oxidase in Mouse RAW264.7 MacrophagesAlcohol Abuse is Associated with Enhanced Pulmonary and Systemic Xanthine Oxidoreductase Activity.Uric acid promotes vascular stiffness, maladaptive inflammatory responses and proteinuria in western diet fed mice.Xanthine Oxidase Induces Foam Cell Formation through LOX-1 and NLRP3 Activation.Eating the Dead to Keep Atherosclerosis at Bay.Uric Acid Is Associated With Inflammation, Coronary Microvascular Dysfunction, and Adverse Outcomes in Postmenopausal Women.XOR inhibition with febuxostat accelerates pulmonary endothelial barrier recovery and improves survival in lipopolysaccharide-induced murine sepsis.Oxidative Stress-Mediated Atherosclerosis: Mechanisms and TherapiesFebuxostat protects rats against lipopolysaccharide-induced lung inflammation in a dose-dependent manner.Honey as an apitherapic product: its inhibitory effect on urease and xanthine oxidase.Febuxostat exerts dose-dependent renoprotection in rats with cisplatin-induced acute renal injury.Cafestol Inhibits Cyclic-Strain-Induced Interleukin-8, Intercellular Adhesion Molecule-1, and Monocyte Chemoattractant Protein-1 Production in Vascular Endothelial Cells.Nanoparticles in Medicine: A Focus on Vascular Oxidative Stress
P2860
Q26747249-766D06D4-8592-4C3E-8CD3-9763CC1E51D9Q26996416-96830A42-FAB8-416E-9C55-8C814DB7269DQ28354735-34F1F37D-21B0-4D34-98BD-5A6EA65B8F81Q33624829-530E7298-9CAB-4815-A67B-503B07C268E9Q33632726-1705A2DA-AEF7-454A-B111-A633A4366FAFQ33683082-BF221032-03A9-4A64-A90C-10818A094542Q33797478-A01C892E-FA6F-4EA5-ABEB-CF3870D9F15CQ33885504-EB83DD02-586B-4CBC-8EA2-B1F3C0B9169BQ35730004-D8628BF7-C8D4-487F-9191-4E7F0CA303DAQ36354759-BD2D03C3-AB80-41F5-B41D-0E72B487CFEEQ37012131-81A163F8-337A-4A8E-B167-2AE3F82FBB3FQ37018125-F262A891-3D10-474A-8C62-4DF4A029B6CAQ37084383-6EA6FCB1-C6B4-499F-BCF4-08C20CFAA1D2Q38609440-AC0A6DBF-D662-476E-8BB3-8B509E455A38Q38648316-EC9F603A-884D-4D0B-BAEF-E8F00C72AEA2Q38721496-290CAD91-7F85-4CDA-9EE6-E9F79FC44A4EQ39134393-8353B6AA-7D3E-4A79-B331-C940FE9375ADQ40417250-FDB8AB7E-98EE-4A7E-80CA-8A27B809FE68Q41386068-311691AB-B0D9-4909-8469-8E38B53F90B6Q41526360-15CCF9FC-AEAC-4C22-BA04-682EE1D10AF6Q46225596-5EF0E7D7-84FF-4FA5-8299-755B7444821EQ46733539-18940D9C-0AC5-4A5C-8A98-8A8A69A6AC1AQ50850318-F727B6C4-4A2C-4D9D-83FC-BE3D50F537AFQ54977487-826CED54-F22C-410D-B5BC-639CAA68C1AFQ57821326-3B725214-6346-4DC8-B228-88FEA8B021CF
P2860
Xanthine oxidase inhibition by febuxostat attenuates experimental atherosclerosis in mice.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on April 2014
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Xanthine oxidase inhibition by ...... ental atherosclerosis in mice.
@en
Xanthine oxidase inhibition by ...... ental atherosclerosis in mice.
@nl
type
label
Xanthine oxidase inhibition by ...... ental atherosclerosis in mice.
@en
Xanthine oxidase inhibition by ...... ental atherosclerosis in mice.
@nl
prefLabel
Xanthine oxidase inhibition by ...... ental atherosclerosis in mice.
@en
Xanthine oxidase inhibition by ...... ental atherosclerosis in mice.
@nl
P2093
P2860
P356
P1433
P1476
Xanthine oxidase inhibition by ...... ental atherosclerosis in mice.
@en
P2093
Alexander So
Annette Ives
Chieko Matsui
Johji Nomura
Mizuho Tamura
Nathalie Busso
Syunsuke Tsujimoto
Takashi Shirakura
Tsunefumi Kobayashi
Yoshihiro Yamanaka
P2860
P2888
P356
10.1038/SREP04554
P407
P577
2014-04-01T00:00:00Z
P5875
P6179
1043428246